Study to Continue Treatment With Darolutamide in Patients Who Have Been Participating in Previous Darolutamide Studies Supported by Bayer
Clinical trial NCT04464226 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04464226
- Sponsor
- Bayer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-20
- Primary completion
- 2028-06-26
- Enrollment
- 402
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.